Your search for non small cell lung cancer returned 65 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
Brian Park, PharmD remove
Home remove

Your search for non small cell lung cancer returned 65 results

Sort Results:

Relevant Recent
News

Rybrevant Approved for NSCLC With EGFR Exon 20 Insertion Mutations

The approval was based on data from the phase 1 CHRYSALIS trial that evaluated Rybrevant in 81 patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations whose disease had progressed on or after platinum-based chemotherapy.